Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool

BACKGROUND: Although fecal microbiota transplant has been used to prevent recurrent Clostridioides difficile infection (rCDI), documented pathogen transmissions highlight inherent safety risks of minimally processed stool. We describe manufacturing processes for fecal microbiota spores, live (VOWST;...

Descripción completa

Detalles Bibliográficos
Autores principales: McChalicher, Christopher W J, Lombardo, Mary-Jane, Khanna, Sahil, McKenzie, Gregory J, Halvorsen, Elizabeth M, Almomani, Sanabel, Schuster, Brian, Hasson, Brooke R, McGovern, Barbara H, Ege, David S, Auniņš, John G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640771/
https://www.ncbi.nlm.nih.gov/pubmed/37540090
http://dx.doi.org/10.1093/infdis/jiad298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640771/
https://www.ncbi.nlm.nih.gov/pubmed/37540090
http://dx.doi.org/10.1093/infdis/jiad298

Ejemplares similares